Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also the world leader in microbial control providing innovative, chemistry-based and related solutions to destroy or to selectively inhibit the growth of harmful microorganisms. Its activities encompass the areas of water treatment, personal care, health and hygiene, industrial preservation, materials protection, and wood treatment. In addition, Lonza is a leader in cell-based research, endotoxin detection and cell therapy manufacturing. Furthermore, the company is a leading provider of value chemical and biotech ingredients to the nutrition and agro markets.
Type
Public
HQ
Basel, CH
Founded
1897
Employees
9,931 (est)

Lonza Locations

Basel, CH

Lonza Metrics

Lonza Summary

Founding Date

1897

Market capitalization

€8.59 B

Closing share price

€169

Lonza Market Value History

Lonza Online Presence

Lonza News

Lonza Company Life